AEPCX
Price
$64.00
Change
+$0.48 (+0.76%)
Updated
Nov 12 closing price
Net Assets
138.09B
AFCMX
Price
$19.44
Change
+$0.05 (+0.26%)
Updated
Nov 12 closing price
Net Assets
157.66M
Interact to see
Advertisement

AEPCX vs AFCMX

Header iconAEPCX vs AFCMX Comparison
Open Charts AEPCX vs AFCMXBanner chart's image
American Funds EUPAC C
Price$64.00
Change+$0.48 (+0.76%)
VolumeN/A
Net Assets138.09B
American Century Focused Intl Gr R6
Price$19.44
Change+$0.05 (+0.26%)
VolumeN/A
Net Assets157.66M
AEPCX vs AFCMX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. AFCMX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and AFCMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 138B vs. AFCMX (158M). AEPCX pays higher dividends than AFCMX: AEPCX (0.15) vs AFCMX (0.08). AEPCX was incepted earlier than AFCMX: AEPCX (25 years) vs AFCMX (10 years). AEPCX (1.57) is less costly to investors than AFCMX (0.74). AFCMX is a more actively managed with annual turnover of: 82.00 vs. AEPCX (35.00). AFCMX has a lower initial minimum investment than AEPCX: AFCMX (0) vs AEPCX (250). AEPCX annual gain was more profitable for investors over the last year : 16.12 vs. AFCMX (13.85). AFCMX return over 5 years is better than : 8.79 vs. AEPCX (6.62).
AEPCXAFCMXAEPCX / AFCMX
Total Expense Ratio1.570.74212%
Annual Report Gross Expense Ratio1.570.74212%
Fund Existence25 years10 years-
Gain YTD23.86316.968141%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets138B158M87,342%
Annual Yield % from dividends0.150.08195%
Returns for 1 year16.1213.85116%
Returns for 3 years34.3331.32110%
Returns for 5 years6.628.7975%
Returns for 10 years42.78N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSAX66.770.64
+0.97%
BlackRock Health Sciences Opps Inv A
POLEX10.150.01
+0.10%
Polar Capital Emerging Market Strs Instl
FBTTX33.48N/A
N/A
Fidelity Advisor Biotechnology M
ALABX13.55N/A
N/A
ALPS/Smith Balanced Opportunity A
GLVIX96.86-0.12
-0.12%
Invesco Global Focus R6